[pp.int.general] research funding

[Amelia Andersdotter]

Politically, the most interesting issue to deal with at this time at a 
European level is how to deal with public-private partnerships (PPPs) 
and joint undertakings (JUs). Which financial instruments do we use to 
incentivise particular kinds of development and through which agents? 
How do we make goal formulation?

It's been one of the bigger discussions around the Horizon 2020 package 
(EU research funding budget, framework program 8) and will continue to 
be an evolving debate in the coming six months.

The line that I have been pushing in Brussels together with my 
colleague, Christian Engström, is the need to adapt particularly results 
management to different industry sectors in cases of PPPs, the need for 
an open access by default policy in the fields of research results, 
analysis and data, and an increased need for transparency and 
accountability in the funding calls for especially projects co-financed 
by the private sector.

Also, with private educational facilities playing an increasingly 
important role in many MS frameworks, it is reasonable to not limit a 
public-private partnership to collaborations between public institutions 
and private sectors, but, say, public entities.

We also call for a separation between funds going into SMEs (COSME) and 
fundamental research (Horizon 2020), so as to not create the illusion of 
the Union spending money on research when in fact we're using the money 
for marketization support to small market players. Unfortunately member 
states have been very unwilling to listen to these calls, and therefore 
support actions at a MS level would be highly appreciated. Especially in 
Sweden, the Netherlands and the UK.

best regards,

Amelia Andersdotter

Pe 27.07.2012 20:38, Jack Allnutt et al au scris:

research funding